Healthcare Global Enterprises Limited

HealthCare Global Enterprises Limited informed the National Stock Exchange of India Limited and BSE Limited that it has furnished details of securities dematerialized and/or rematerialized during the quarter ended September 30, 2026, pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, and enclosed a certificate from Kfin Technologies Limited, its Registrar to Issue and Share Transfer Agent, dated October 15, 2026.

HealthCare Global Enterprises Limited will hold a board meeting on November 5, 2026, to approve the unaudited financial results for both standalone and consolidated entities for the quarter and half year ended September 30, 2026, according to a regulatory filing. The trading window for designated persons and their immediate relatives will be closed from October 1, 2026, and remain so for 48 hours after the financial results are declared.

India Glycols Ltd, Anand Rathi Wealth Ltd, Aditya Vision Ltd and Caplin Point Laboratories Ltd are among the other losers in the BSE's 'A' group today, 09 October 2026.Healthcare Global Enterprises Ltd lost 7.31% to Rs 592.1 at 14:48 IST.The stock was the biggest loser in the BSE's 'A' group.On the BSE, 40421 shares were traded on the counter so far as against the average daily volumes of 70566 shares in the past one month.India Glycols Ltd crashed 7.23% to Rs 331.8. The stock was the second biggest loser in 'A' group.On the BSE, 72376 shares were traded on the counter so far as against the average daily volumes of 1.2 lakh shares in the past one month.Anand Rathi Wealth Ltd tumbled 4.49% to Rs 2047.65. The stock was the third biggest loser in 'A' group.On the BSE, 59668 shares were traded on the counter so far as against the average daily volumes of 18456 shares in the past one month.Aditya Vision Ltd pared 3.97% to Rs 579.7. The stock was the fourth biggest loser in 'A' group.On the BSE, 4948 shares were traded on the counter so far as against the average daily volumes of 8518 shares in the past one month.Caplin Point Laboratories Ltd fell 3.95% to Rs 2450. The stock was the fifth biggest loser in 'A' group.On the BSE, 15038 shares were traded on the counter so far as against the average daily volumes of 12533 shares in the past one month.

HealthCare Global Enterprises Limited announced that its step-down subsidiary, Healthcare Global (Kenya) Private Limited, has acquired 10 ordinary shares of Advanced Molecular Imaging Limited from Meditec Systems Limited for 42,150 Kenyan Shillings, equivalent to approximately Rs 31,288 as of October 5, 2026. The acquisition increased Healthcare Global (Kenya)'s shareholding in Advanced Molecular Imaging Limited from 50% to 50.10%, making Advanced Molecular Imaging Limited a subsidiary of Healthcare Global (Kenya) and a step-down subsidiary of HealthCare Global Enterprises Limited.

HealthCare Global Enterprises Limited informed the National Stock Exchange of India Limited and BSE Limited that it will close its trading window for securities from Thursday, October 01, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter and half year ending September 30, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

CARE Ratings Ltd. has reported that a company has largely deployed proceeds from a public offering, with funds used for debt prepayment, acquisition of a 34% stake in Vizag Hospital, and general corporate purposes. Approximately Rs. 95.83 crore was allocated to general corporate purposes, covering expenses such as salaries, consultancy, and vendor payments, as outlined in the offer document. The report notes that issue-related expenses were lower than initially projected, allowing for a reallocation of Rs. 0.26 crore to general corporate purposes. All commitments were completed within the timeframe specified in the offer document by Fiscal Year 2027, and the monitoring agency relied on information provided by the company and third-party sources, disclaiming any independent audit or legal liability.

Healthcare Global Enterprises Ltd share price ticked higher by 0.17% to Rs 670.5 after the company's net profit surged by 307.43% to Rs 16.46 crore, while revenue from operations improved marginally 6.63% to Rs 693.39 crore in Q2FY26 over Q1FY26. The market capitalization of Hospital industry group stocks on BSE stood at Rs 5.11 lakh crore, easing 5.20%. It has increased 13.41% over last one week and soared by 31.33% in last one month while the market capitalization of Healthcare Global Enterprises Ltd has marginally improved by 0.28% and 10.80% in the same period respectively. Profit before tax (PBT) of Healthcare Global Enterprises Ltd stood at Rs 25.03 crore in Q2 FY26, surging by 109.98% year-on-year, and jumping 1902.40% quarter-on-quarter. EBITDA came in at Rs 110 crore, gaining 9.08% YoY and slipping 1.68% sequentially. Total expenses grew marginally by 9.02% to Rs 643.26 crore in Q2FY26 over Q2FY25. During the quarter, employee benefits expense was at Rs 104.52 crore, surging 13.03% YoY. For the TTM ended FY26, revenue from operations improved 16.26% to Rs 2218.14 crore, while net profit rose by 18.18% to Rs 48.83 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 34863% to Rs 352.47 crore, and PBT fell 15.89% to Rs 56.96 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 317.11 crore in FY26, as against Rs 284.58 crore in FY25. Healthcare Global Enterprises Ltd rallied 9.55% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 2.64% during the same period.

HealthCare Global Enterprises Limited announced that its board of directors approved the re-appointment of M/s. Rao Murthy & Associates, Cost Accountants, Bengaluru, as the company’s Cost Auditor for the financial year 2026-27, with Firm Registration No. 000065.

HealthCare Global Enterprises Limited announced that there was no deviation or variation in the utilization of funds raised through its Rights Issue of Rs 424.68 crore during the quarter ended June 30, 2026, from the objects stated in the Letter of Offer dated February 24, 2026, according to a filing with the National Stock Exchange of India Limited and BSE Limited. The company noted a minor difference in issue-related expenses, with Rs 4.81 crore utilized against an estimated allocation of Rs 5.07 crore, resulting in an additional Rs 0.26 crore being used for general corporate purposes.

HealthCare Global Enterprises Limited announced that its board approved a further investment of up to Rs 16 crore in its wholly owned subsidiary, HCG Rajkot Hospitals LLP, for repayment of dues, working capital, and general corporate purposes. HCG Rajkot, incorporated on September 22, 2017, operates a 147-bed cancer specialty hospital in Rajkot, Gujarat, with a turnover of approximately Rs 60.67 crore for the financial year ended March 31, 2026, and the investment is expected to be completed on or before September 30, 2026.